ARID1A and neuroblastoma: Interestingly, in the MYCN-amplified NGP neuroblastoma cell line, depletion of ARID1A using CRISPR-Cas9 promotes the transdifferentiation of NOR cells toward a MES state with increased invasion, migration, and resistance to cisplatin [59].